A systematic review of medication nonadherence in persons with dementia or cognitive impairment

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Smith, Daisy ^a   Lovell, Janaka ^b   Weller, Carolina ^a   Kennedy, Briohny ^a   Winbolt, Margaret ^c   Young, Carmel ^a   Ibrahim, Joseph ^a  

^a MONASH UNIVERSITY   (Australia)

^b BALLARAT HEALTH SERVICES   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; CAREGIVER SUPPORT; COGNITIVE DEFECT; DEMENTIA; EXECUTIVE FUNCTION; HUMAN; LEARNING; MEMORY; REVIEW; SOCIAL COGNITION; SYSTEMATIC REVIEW; TREATMENT REFUSAL; COGNITION DISORDERS; DRUG MISUSE; MEDICATION COMPLIANCE; META ANALYSIS; OUTCOME ASSESSMENT; PHENOTYPE; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

COGNITION DISORDERS; DEMENTIA; HUMANS; MEDICATION ADHERENCE; PATIENT OUTCOME ASSESSMENT; PHENOTYPE; PRESCRIPTION DRUG OVERUSE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85011664399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0170651     Document Type: Review

References (50)

1. World Health Organization. Global status report on noncommunicable diseases 2010. In: description of the global burden of NCDs, their risk factors and determinants [Internet]. Switzerland. 2011 Apr [updated 2016; cited 2016 Apr 5]. Available from: http://www.who.int/nmh/publications/ncd-report2010/en/
2. Chronic Disease Prevention and Health Promotion. Chronic Diseases: The Leading Causes of Death and Disability. In: the United States [Internet]. USA. 2013 [updated 2016 Feb 23; cited 2016 Apr 5]. Available from: http://www.cdc.gov/chronicdisease/overview/index.htm.
3. Schwartz SM, Day B, Wildenhaus K, Silberman A, Wang C, Silberman J. The Impact of an Online Disease Management Program on Medical Costs Among Health Plan Members. Am J Health Promot. 2010; 25(2):126-133. doi: 10.4278/ajhp.091201-QUAL-377 PMID: 21039294
4. World Health Organization. Adherence to long-term therapies: evidence for action, in: Chronic diseases and health promotion [Internet]. Switzerland. 2003 [update 2016; cited 2016 Apr 5]. Available from: http://www.who.int/chp/knowledge/publications/adherence-report/en/
5. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001; 54(12, Supplement 1):S57-S60.
6. Depont F, Berenbaum F, Filippi J, Le Maitre M, Nataf H, Paul C, et al. Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review. PLoS One. 2015. 10(12).
7. Thaler NS, Sayegh P, Arentoft A, Thames AD, Castellon SA, Hinkin CH. Increased Neurocognitive Intra-Individual Variability Is Associated With Declines in Medication Adherence in HIV-Infected Adults. Neuropsychology. 2015; 29(6):919-925. doi: 10.1037/neu0000191 PMID: 25730729
8. Arlt S, Lindner R, Rosler A, Von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs & Aging 2008; 25(12):1033-47.
9. Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother.2012; 10 (3):165-77. doi: 10.1016/j.amjopharm.2012.04.004 PMID: 22657941
10. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs & Aging. 2004; 21(12):793-811.
11. Elliott RA, Goeman D, Beanland C, Koch S. Ability of older people with dementia or cognitive impairment to manage medication regimens: a narrative review. Curr Clin Pharmacol. 2015; 10:213-221. PMID: 26265487
12. Lassen LC. Patient Compliance in General Practice. Scand J Prim Health Care.1989; 7(3):179-180. PMID: 2587874
13. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther.2001; 26(5):331-42. PMID: 11679023
14. Insel K, Morrow D, Brewer B, Figueredo A. Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol Sci Soc Sci.2006; 61(2):102-7.
15. Stilley CS, Bender CM, Dunbar-Jacob J, Sereika S, Ryan CM. The impact of cognitive function on medication management: three studies. J Health Psychol. 2010; 29(1):50-5.
16. Park DC, Morrell RW, Frieske D, Kincaid D. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol Aging.1992; 7(2):252-6. PMID: 1610514
17. Hayes TL, Cobbinah K, Dishongh T, Kaye JA, Kimel J, Labhard M, et al. A Study of Medication-Taking and Unobtrusive, Intelligent Reminding. Telemed J E Health. 2009; 15(8):770-776. doi: 10.1089/tmj. 2009.0033 PMID: 19780692
18. Hawkins LA, Kilian S, Firek A, Kashner TM, Firek CJ, Silvet H. Cognitive impairment and medication adherence in outpatients with heart failure. Heart Lung.2012; 41(6):572-82. doi: 10.1016/j.hrtlng.2012. 06.001 PMID: 22784869
19. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al., Interventions for enhancing medication adherence. The Cochrane Library. 2014; 11.
20. Thiruchselvam T, Nagile G, Moineddin R, Charles J, Orlando L, Jaglal S, et al. Risk factors for medication nonadherence in older adults with cognitive impairment who live alone. Int J Geriatr Psychiatry. 2012; 27(12):1275-82. doi: 10.1002/gps.3778 PMID: 22337284
21. Stoehr GP, Lu SY, Lavery L, Bilt JV, Saxton JA, Chang CC, et al. Factors associated with adherence to medication regimens in older primary care patients: The Steel Valley Seniors Survey. Am J Geriatr Pharmacother. 2008; 6(5):255-63. doi: 10.1016/j.amjopharm.2008.11.001 PMID: 19161928
22. American Psychiatric Association. Neurocognitive Disorder, Diagnostic and statistical manual of mental disorders. 2013 ( 5ed.)., Washington, DC: American Psychiatric Publishing.
23. Liberati A, Altman DG, Tetzlaff J, Murlow C, Gøtzsche, PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339.
24. National Institute of Health. Quality assessment tool for observational cohort and cross-sectional studies. USA. 2014 [updated Mar 2014; cited May 5 2016]. Available from: http://www.nhlbi.nih.gov/healthpro/guidelines/in-develop/cardiovascular-risk-reduction/tools/cohort.
25. Boucher L, Renvall MJ, Jackson JE. Cognitively impaired spouses as primary caregivers for demented elderly people. J Am Geriatr Soc. 1996; 44(7):828-31. PMID: 8675933
26. Conn VS, Taylor S, Miller R. Cognitive impairment and medication adherence. J Gerontol Nurs. 1994; 20(7):41-7. PMID: 8046218
27. Cotrell V, Wild K, Bader T. Medication management and adherence among cognitively impaired older adults. J Gerontol Soc Work. 2006; 47(3-4):31-46. doi: 10.1300/J083v47n03-03 PMID: 17062521
28. Fulmer T, Gurland B. Evaluating the caregiver's intervention in the elder's task performance: capacity versus actual behavior. Int J Geriatr Psychiatry. 1997; 12(9):920-5. PMID: 9309470
29. Kamimura T, Ishiwata R, Inoue T. Medication reminder device for the elderly patients with mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2012; 27(4):238-42. doi: 10.1177/1533317512450066 PMID: 22739031
30. Mackin RS, Arean PA. Cognitive and psychiatric predictors of medical treatment adherence among older adults in primary care clinics. Int J Geriatr Psychiatry. 2007; 22(1):55-60. doi: 10.1002/gps.1653 PMID: 17006873
31. Poon I, Lal LS, Ford ME, Braun UK. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: A national cohort study. Ann Pharmacother. 2009; 43(2):185-93. doi: 10. 1345/aph.1L368 PMID: 19193586
32. Smith GE, Lunde AM, Hathaway JC, Vickers KS. Telehealth home monitoring of solitary persons with mild dementia. Am J Alzheimers Dis Other Demen. 2007; 22(1):20-6. PMID: 17533998
33. Cameron J, Worrall-Carter L, Page K, Riegel B, Lo SK, Stewart S. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail. 2010; 12(5):508-15. doi: 10.1093/eurjhf/hfq042 PMID: 20354031
34. Foebel AD, Hirdes JP, Heckman GA. Caregiver status affects medication adherence among older home care clients with heart failure. Aging Clin Exp Res. 2012; 24(6):718-21. doi: 10.3275/8475 PMID: 22732397
35. Okuno J, Yanagi H, Tomura S. Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur J Clin Pharmacol. 2001; 57(8): 589-94. PMID: 11758637
36. Julius RJ, Novitsky MA, Dubin WR. Medication Adherence: A Review of the Literature and Implications for Clinical Practice. J Psychiatr Pract. 2009; 15(1):34-44. doi: 10.1097/01.pra.0000344917.43780.77 PMID: 19182563
37. Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of Executive Function Predict Instrumental Activities of Daily Living in Community-Dwelling Older Individuals. App Neuropsychol. 2002; 9(3):187-191.
38. Klepin HG, Geiger AM, Bandos H, Costantino JP, Rapp S, Sink KM, et al. Cognitive factors associated with adherence to oral anti-estrogen therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study. Cancer Prev Res. 2014; 7(1):161-168.
39. Becker BW, Thames AP, Woo E, Castellon SA, Hinkin CH. Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected Adults. AIDS Behav. 2011; 15(8):1888-94. doi: 10.1007/s10461-011-9924-z PMID: 21437726
40. Ho PM, Bryson CL, Rumsfeld JS. Medication Adherence: Its Importance in Cardiovascular Outcomes. Circulation. 2009; 119(23):3028-3035. doi: 10.1161/CIRCULATIONAHA.108.768986 PMID: 19528344
41. Boustani MM, Callahan CM, Unverzagt FW, Austrom MG, Perkins AJ, Fultz BA, et al. Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med. 2005; 20(7):572-577. doi: 10.1111/j.1525-1497.2005.0126.x PMID: 16050849
42. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003; 2 (3):219-28. PMID: 14622630
43. Sturgess IK, Hughes CM, McElnay JC, King M. Identifying non-compliance of elderly patients: a comparison of three methods. In: British Pharmaceutical Conference. 1998, Pharmaceutical Journal: London. p. 348-9.
44. Bunn F, Burn AM, Goodman C, Rait G, Norton S, Robinson S, et al. Comorbidity and dementia: a scoping review of the literature. BMC Med. 2014; 12(1):192.
45. Corsonello A, Pendone C, Garasto S, Maiuri G, Carelli A, Zottola C, et al. The impact of comorbidity on medication adherence and therapeutic goals.BMC Geriatr. 2010.5-7
46. Bunn F, Goodman C, Brayne C, Norton S, Rait G, Robinson L, et al. Comorbidity and Dementia: Improving Healthcare for People with Dementia.(CoDem). 2013.
47. Lorig KR, Holman H. Self-management education: History, definition, outcomes, and mechanisms. Ann Behav Med. 2003; 26(1):1-7. PMID: 12867348
48. Andrade AS, McGruder HF, Wu AW, Celane SA, Skolasky RL, Selnes OA, et al. A Programmable Prompting Device Improves Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Subjects with Memory Impairment. Clin Infect Dis. 2005; 41(6):875-882. doi: 10.1086/432877 PMID: 16107989
49. Burkhart P, Sabate E. Adherence to Long-Term Therapies: Evidence for Action. J Nurs Scholarsh. 2003.; 35(3):207. PMID: 14562485
50. Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist review-a new method of systematic review designed for complex policy interventions. J Health Ser Res Policy. 2005; 10:21-34.